Table I:
Skin prick test and intradermal test, and specific Ig E results
| Reagent | Skin prick test | Intradermal test (standard concentration) | Specific Ig E (Reference <0.35KUA/L) | Skin prick test (repeated) | Intradermal test (strong concentration) |
|---|---|---|---|---|---|
| Neuromuscular Blocking Agents | |||||
| Atracurium | Negative | Negative | Not available | Negative | Negative |
| Suxamethonium | Negative | Negative | Not available | Negative | Negative |
| Rocuronium | Negative | Negative | Not available | Negative | Negative |
| Hypnotics | |||||
| Propofol | Negative | Negative | Not available | Negative | Negative |
| Analgesic Agents | |||||
| Fentanyl | Negative | Negative | Not available | Negative | Negative |
| Morphine** | Negative | Negative | Negative | Negative | Negative |
| Antiseptic Agents | |||||
| Povidone-iodine | Negative | Negative | Not available | Negative | Negative |
| Chlorhexidine | Negative | Negative | 0.77 KUA/L | Positive | Positive |
| Other | |||||
| Latex* | Negative | - | rHev B8 negative | ||
| rHev B6 negative | Negative | - |
* Recombinant latex allergens are used to test for latex-specific Ig E level.
** Morphine-based immunoassay is used to detect sensitization against the antigenic quaternary ammonium (NH4+) epitope of neuromuscular blocking agents.
*** Antibiotics are not tested as the patient is given regular doses of cefuroxime in the ward without any complication.